
LABU: This 3X Leveraged Bull ETF Fails To Raise Any Optimism
Pgiam/iStock via Getty Images I covered the Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) at the end of Q1 2022. On 30th March, the stock was trading around $18 (with day’s high recorded at […]